
4 Cours
Healthcare Professionals
This program is a CCCEP accredited Continuing Education Certificate Program on Cannabis and Patient Care in Pharmacy. CCCEP Number 1525-2021-3256-I-P, 10 CEUs. expires on 2023-09-07.
This program is also an approved online continuing education program on medical cannabis by the Ontario College of Pharmacists (OCP).
It is comprised of six evidence-based modules that provide the necessary knowledge and skills required to respond to inquiries by clients, patients, and other healthcare providers on cannabis legal status, usage, proper assessment, monitoring, and care plan development.
General learning objectives:
Disclosure:
Authors: Kaivan Talachian Pharm.D., R.Ph. & Farhang Modaresi M.D., M.BE
The authors are founders of Concinto and have no current relationship with other commercial entities. They have not received any sponsorship or funding to develop this program. Authors were employed in the past by CannTrust Inc.
Healthcare Professionals
This program is a Canadian Council on Continuing Education in Pharmacy (CCCEP) accredited continuing education program. CCCEP Number 1525-2021-3255-I-P, 2.0 CEUs.
This program is also an approved online continuing education program on medical cannabis by the Ontario College of Pharmacists (OCP).
This course is designed to explore the inter-relationship between cannabinoids and opioids and potential clinical implications on opioid crisis management.
It provides you with knowledge about the potential benefits of cannabinoid acids and the relationship between hemp seed oil and Essential Fatty Acids to the cannabinoids.
You will also, learn about other plants that produce phytocannabinoids.
Learners are expected to be familiar with the main components of the cannabis plant, the major difference between cannabis constituents, the evidence about the endocannabinoid system, cannabinoid pharmacokinetics, pharmacodynamics, safety, side effects, precautions, contraindications, and potential drug-drug interactions.
1. Discuss the current opioid crisis and recent clinical practice guidelines in Canada
2. Explain the potential cannabis and opioid inter-relationship
3. Explain the opioid reduction strategies through using cannabis for non-cancer pain patients
4. Discuss the current evidence on the potential benefits of cannabinoid acids
5. Discuss other plants that produce phytocannabinoids and explain hemp oil and essential fatty acids' relationship to medical cannabis
Before starting this course, we recommend learners complete Medical Cannabis Core Education Program (MCCEP).
Disclosure:
Authors: Kaivan Talachian Pharm.D., R.Ph. & Farhang Modaresi M.D., M.BE
The authors are founders of Concinto and have no current relationship with other commercial entities. They have not received any sponsorship or funding to develop this program. Authors were employed in the past by CannTrust Inc.
Healthcare Professionals
This program is adapted for Australia based on a Canadian Council on Continuing Education in Pharmacy (CCCEP) accredited Continuing Education Certificate Program on Cannabis and Patient Care.
It is comprised of six evidence-based modules that provide the necessary knowledge and skills required to respond to inquiries by clients, patients, and other healthcare providers on cannabis legal status, usage, proper assessment, monitoring, and care plan development.
1. Understand the legislation, regulations, policies, and guidelines related to cannabis.
2. Become familiar with knowledge sources to access reliable data.
3. Describe the main components of the cannabis plant, the major difference between cannabis constituents, the evidence about the endocannabinoid system, and cannabinoid interactions with different organs.
4. Explain cannabinoid pharmacokinetics, pharmacodynamics, safety, side effects, precautions, contraindications, and potential drug-drug interactions.
5. Explain the clinical relevance of different administration routes and describe available dosage forms and their relevant clinical differences.
6. Apply clinical knowledge and effective communication and collaboration with the patient circle of care for evidence-based patient assessment, care plan development, monitoring and follow-up.
Lesson 1: Patients' scenarios
Lesson 2: Cannabis plant
Lesson 3: Medical Cannabis Regulations in Australia
Lesson 4: Perceived barriers
Lesson 5: Statistical data
Lesson 1: Cannabis and its varieties
Lesson 2: Terpenes & the entourage effects
Lesson 3: Introduction to the Endocannabinoid System (ECS)
Lesson 1: Cannabinoid pharmacokinetics
Lesson 2: Cannabinoid pharmacodynamics
Lesson 3: Cannabis safety & primary side effects
Lesson 1: Potential therapeutic use
Lesson 2: Precautions and contraindications
Lesson 3: Potential drug interactions
Lesson 1: Cannabis dosage forms
Lesson 2: Dosing guide
Lesson 1: Care planning
Lesson 2: Patient assessment
Lesson 3: Authorizing medical cannabis
Lesson 4: Monitoring and follow-up
Authors: Kaivan Talachian Pharm.D., R.Ph. & Farhang Modaresi M.D., M.BE
The authors are founders of Concinto and have no current relationship with other commercial entities. They have not received any sponsorship or funding to develop this program. Authors were employed in the past by CannTrust Inc.
Healthcare Professionals
EU-MCCEP
This program is adapted for the European Union based on a Canadian Council on Continuing Education in Pharmacy (CCCEP) accredited Continuing Education Certificate Program on Cannabis and Patient Care.
It comprises six evidence-based modules that provide the necessary knowledge and skills required to respond to inquiries by clients, patients, and other healthcare providers on cannabis legal status, usage, proper assessment, monitoring, and care plan development.
General learning objectives:
1. Understand the legislation, regulations, policies, and guidelines related to cannabis.
2. Become familiar with knowledge sources to access reliable data.
3. Describe the main components of the cannabis plant, the major difference between cannabis constituents, the evidence about the endocannabinoid system, and cannabinoid interactions with different organs.
4. Explain cannabinoid pharmacokinetics, pharmacodynamics, safety, side effects, precautions, contraindications, and potential drug-drug interactions.
5. Explain the clinical relevance of different administration routes and describe available dosage forms and their relevant clinical differences.
6. Apply clinical knowledge and effective communication and collaboration with the patient circle of care for evidence-based patient assessment, care plan development, monitoring and follow-up.
Module 1:
Lesson 1: Patients' scenarios
Lesson 2: Cannabis plant
Lesson 3: Medical Cannabis Regulations in the EU
Lesson 4: Perceived barriers
Lesson 5: Statistical data
Module 2:
Lesson 1: Cannabis and its varieties
Lesson 2: Terpenes & the entourage effects
Lesson 3: Introduction to the Endocannabinoid System (ECS)
Module 3:
Lesson 1: Cannabinoid pharmacokinetics
Lesson 2: Cannabinoid pharmacodynamics
Lesson 3: Cannabis safety & primary side effects
Module 4:
Lesson 1: Potential therapeutic use
Lesson 2: Precautions and contraindications
Lesson 3: Potential drug interactions
Module 5:
Lesson 1: Cannabis dosage forms
Lesson 2: Dosing guide
Module 6:
Lesson 1: Care planning
Lesson 2: Patient assessment
Lesson 3: Authorizing medical cannabis
Lesson 4: Monitoring and follow-up
Authors: Kaivan Talachian Pharm.D., R.Ph. & Farhang Modaresi M.D., M.BE
The authors are founders of Concinto and have no current relationship with other commercial entities. They have not received any sponsorship or funding to develop this program. Authors were employed in the past by CannTrust Inc.
EST: 10 Hours
If you have not registered with our site, please create an account to be able to enroll in our courses.